Biotech | October 11, 2025
Dr. Jitendra Singh inaugurates 10th Annual "Cell and Gene Therapy" symposium
Several technologies for hemoglobinopathies are being transferred to commercial partners
Several technologies for hemoglobinopathies are being transferred to commercial partners
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants
New study presents a human-relevant stress model for assessing potential therapeutics
This collaboration aims to combine Molcure’s cutting-edge AI technology with Boehringer Ingelheim’s extensive expertise in drug discovery
If approved, tavapadon will enhance AbbVie's leadership in Parkinson's disease by providing patients with a once daily oral treatment option
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population
Paroxetine Extended-Release Tablets USP, 25 mg and 37.5 mg, are indicated for the treatment of major depressive disorder
BIL also holds an option to increase its equity stake by an additional 15%
IND application for EB-003 expected in early 2026
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
Subscribe To Our Newsletter & Stay Updated
